发明名称 Anthranilic acid amides and pharmaceutical use thereof
摘要 <p>The invention relates to anthranilic acid amide derivatives of formula I wherein Ar is represented by the subformula I a wherein R a represents H or lower alkyl, and R 1 represents H or perfluoro lower alkyl, R 2 represents H, halogen, C 2 -C 7 alkyl, C 2 -C 7 alkenyl or lower alkynyl; or Ar is represented by the subformula I b , and R 1 represents perfluoro lower alkyl, and R 2 represents bromo, iodo, C 2 -C 7 alkyl, C 2 -C 7 alkenyl or lower alkynyl, or R 1 represents H, and R 2 represents fluoro, bromo, indo, ethyl, C 5 -C 7 alkyl, C 2 -C 7 alkenyl or lower alkynyl; to N-oxides and tautomers thereof, and to salts of such anthranilic acid amides, its N-oxides and tautomers; to processes for their preparation; to their application in the treatment of the human or animal body, to the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment especially of a neoplastic disease, such as a tumor disease, of retinopathy or age-related macular degeneration; to a method for the treatment of such diseases in animals; and to the use of such a compound - alone or in combination with one or more other pharmaceutically active compounds - for the manufacture of a pharmaceutical preparation for the treatment of a neoplastic disease, of retinopathy or age-related macular degeneration.</p>
申请公布号 EP2269988(A2) 申请公布日期 2011.01.05
申请号 EP20100180423 申请日期 2002.11.07
申请人 NOVARTIS AG 发明人 BOLD, GUIDO;FURET, PASCAL;MANLEY, PAUL W.
分类号 A61K31/44;C07D213/38;A61K31/165;A61K31/166;A61K31/4409;A61P3/10;A61P9/10;A61P11/06;A61P15/00;A61P17/06;A61P19/02;A61P27/00;A61P27/06;A61P29/00;A61P35/00;A61P35/02;C07C231/12;C07C237/40;C07D213/89 主分类号 A61K31/44
代理机构 代理人
主权项
地址